KaranfilMAkbugaKYaylaC. et al.Nicorandil and contrast-induced nephropathy. Angiology. 2019. doi:10.1177/0003319719855156
2.
ZhangPLiWYYangSC. et al.Preventive effects of nicorandil against contrast-induced nephropathy in patients with moderate renal insufficiency undergoing percutaneous coronary intervention. Angiology. 2019;71(2):183–188. doi:10.1177/0003319719841733.
3.
ShamsMDehghanPHosseinpanahF. Metformin and intravascular contrast media: what to do in patients receiving both: a narrative review. Novel Biomed. 2017;5(3):138–45.
4.
SigtermanTAKrasznaiAGSnoeijsMG. et al.Contrast induced nephropathy and long-term renal decline after percutaneous transluminal angioplasty for symptomatic peripheral arterial disease. Eur J Vasc Endovasc Surg. 2016;51:386–93. doi:10.1016/j.ejvs.2015.10.028
5.
Yi-MingMuJiLNNingG. et al.Expert consensus on clinical application of metformin. Chinese J Practical Internal Med. 2014;34:974–83. doi:0.3760/cma.j.issn.0529-5815.2018.03.002
